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Abstract We previously reported that microRNA-30
(miR-30) expression was initiated by radiation-induced
proinflammatory factor IL-1b and NFkB activation in
mouse and human hematopoietic cells. However, the
downstream effectors of miR-30 and its specific role in
radiation-induced cell death are not well understood. In the
present study, we evaluated effects of radiation on miR-30
expression and activation of intrinsic apoptotic pathway
Bcl-2 family factors in in vivo mouse and in vitro human
hematopoietic cells. CD2F1 mice and human CD34? cells
were exposed to different doses of gamma-radiation. In
addition to survival studies, mouse blood, bone marrow
(BM) and spleen cells and human CD34? cells were col-
lected at 4 h, and 1, 3 and 4 days after irradiation to
determine apoptotic and stress response signals. Our results
showed that mouse serum miR-30, DNA damage marker c-
H2AX in BM, and Bim, Bax and Bak expression, cyto-
chrome c release, and caspase-3 and -7 activation in BM
and/or spleen cells were upregulated in a radiation dose-
dependent manner. Antiapoptotic factor Mcl-1 was sig-
nificantly downregulated, whereas Bcl-2 was less changed
or unaltered in the irradiated mouse cells and human
CD34? cells. Furthermore, a putative miR-30 binding site
was found in the 30 UTR of Mcl-1 mRNA. miR-30 directly
inhibits the expression of Mcl-1 through binding to its
target sequence, which was demonstrated by a luciferase
reporter assay, and the finding that Mcl-1 was uninhibited
by irradiation in miR-30 knockdown CD34? cells. Bcl-2
expression was not affected by miR-30. Our data suggest
miR-30 plays a key role in radiation-induced apoptosis
through directly targeting Mcl-1in hematopoietic cells.
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Introduction
More than 50 % of cancer patients receive radiotherapy,
which often results in side effects due to radiation damage
on normal tissue [1]. In addition, nuclear proliferation,
terrorist activities, and the distribution of radioactive
materials increase the risk of incidents involving radiation
injuries. The hematopoietic system is one of the most
radiation-sensitive organs [2]. Ionizing radiation doses
above 1 Gy in humans pose a risk of BM failure [3].
Exposure to c-radiation causes damage to DNA, pro-
tein, and lipids in mammalian cells, leading to ‘‘danger
signals’’ and antigen release. These events could impact
cellular tissue homeostasis and subsequent cell cycle
checkpoint arrest, apoptosis, and stress-related responses.
The effects of radiation on mitochondrial outer membrane
permeabilization (MOMP) are required for activation of
the caspase proteases that cause apoptotic cell death [4].
Radiation as an intrinsic apoptotic stimulus initiates
mammalian cells’ apoptotic program by inhibiting Bcl-2
family antiapoptosis factor Bcl-2, Mcl-1 and Bcl-x, and
triggering conformational changes in Bcl-2-associate X
(Bax) and Bcl-2-antagonist/killer (Bak) proteins that
enable oligomer formation on the mitochondria, causing
MOMP and cytochrome c and other apoptogenic proteins
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in the intermembrane space to leak out [5]. Overex-
pression of Bcl-2 increases hematopoietic stem cell
number and repopulation potential in lethally irradiated
mice [6].
MicroRNAs (miRNA) are a class of small noncoding
RNA molecules (on average 22 nucleotides long) found
in eukaryotic cells. They have the ability to post-tran-
scriptionally regulate gene expression via targeting the 30
untranslated region (UTR) of messenger RNA transcripts
(mRNAs) [7, 8]. miRNA-mediated gene repression
occurs through both translational repression and mRNA
destabilization [9]. Mammalian genomes encode thou-
sands of conserved miRNAs that target mammalian genes
and are abundant in many cell types [10, 11]. miRNAs
could regulate the cellular changes required to establish
stress-induced cell damage phenotypes [12]. On the other
hand, miRNA also can be regulated during its maturation
process, from primary and precursor to mature miRNA
[13], although the underlying mechanisms are not well
understood.
We previously reported that radiation upregulated miR-
30b and miR-30c in human hematopoietic CD34? cells,
and miR-30 played a key role in radiation-induced human
hematopoietic and their niche osteoblast cell damage
through negatively regulating expression of survival factor
REDD1 (regulated in development and DNA damage
responses 1) and inducing apoptosis in these cells.
Knockdown of miR-30c before radiation significantly
increased clonogenicity in irradiated CD34? cells [14].
Recently, we further reported that miR-30 expression in
mouse BM, liver, jejunum and serum was initiated by
radiation-induced proinflammatory factor IL-1b and NFkB
activation. Delta-tocotrienol (DT3), a radioprotector, sup-
pressed miR-30 and protected mice and human
CD34? cells from radiation exposure [15]. Our results
from both in vitro and in vivo studies suggested miR-30 is
an apoptosis inducer after radiation exposure. However the
specific role of miR-30 in radiation-induced apoptotic cell
death and its downstream target factors which caused
mouse and human hematopoietic cell damage are not well
understood. In this study, we extend our findings using
human hematopoietic stem and progenitor CD34? cells
and an in vivo mouse model, to explore the effects and
mechanisms of miR-30 on regulation of apoptotic cell
death signaling in hematopoietic cells after c-radiation.
Materials and methods
Mice and animal care
Twelve- to 14-week-old CD2F1 male mice (Harlan Labo-
ratories, Indianapolis, IN) were used according to methods
described in previous reports [16]. All animals were housed
in an AAALAC-approved facility at the Armed Forces
Radiobiology Research Institute (AFRRI), and the animal
study protocol was approved by the Institutional Animal
Care and Use Committee (IACUC). Mice were acclima-
tized upon arrival and representative animals were
screened for evidence of disease. Animal rooms were
maintained at 20–26 C with 30–70 % humidity on a 12 h
light/dark cycle. Commercial rodent chow (Harlan Teklad
Rodent Diet 8604) was available ad libitum as was acidi-
fied water (pH 2.5–3.0) to control opportunistic infections.
Animals were chosen randomly for each experimental
group.
Human CD341 cells
Human primary hematopoietic CD34? cells were provided
by the Fred Hutchinson Cancer Research Center (Seattle,
WA) as described in previous reports [14]. Thawed
CD34? cells were cultured in serum-free medium con-
sisting of Iscove’s Modified Dulbecco’s Medium (IMDM)
supplemented with BIT 9500 (Stem Cell Technologies,
Tukwila, WA) and penicillin/streptomycin. Recombinant
human (rh) stem cell factor (SCF, 100 ng/ml), rh flt-3
ligand (FL, 100 ng/ml) and rh interleukin-3 (IL-3, 25 ng/
ml) were added. All cytokines were purchased from
PeproTech, Inc. (Rocky Hill, NJ). The cells were incubated
at 37 C with 5 % CO2 [17].
Irradiation procedure
Mice received whole-body irradiation (WBI) in a bilateral
radiation field at AFRRI’s 60Co facility. The alanine/elec-
tron spin resonance (ESR) dosimetry system (American
Society for Testing and Materials, Standard E 1607) was
used to measure dose rates (to water) in the cores of acrylic
mouse phantoms. Control animals were sham-irradiated,
treated in the same manner as the irradiated animals, except
that the 60Co source was not raised from the shielding
water pool. The midline tissue doses to the mice were 5, 8
or 9 Gy at a dose rate of 0.6 Gy/min [16]. Survival was
monitored for 30 days after WBI (N = 20/group). Separate
groups of mice were used for other assays at each of the
four time points (4 h, 1, 3, and 4 days) after sham or c-
irradiation (N = 6/time point). After irradiation, mice were
returned to their home cages with food and water provided
as usual. The day of irradiation was considered day 0.
Human CD34? cells were irradiated at doses of 0, 0.5,
1.0 or 2.0 Gy (0.6 Gy/min); 1.0 and 2.0 Gy are lethal
radiation doses of CD34? cells and 2.0 Gy had been pre-
viously determined to generate one log of cell kill by
clonogenic assay [17]. After irradiation, cells were washed
once and cultured in fresh culture medium.
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Mouse peripheral blood cell counts and serum
and tissue preparation
At 4 h and 1, 3, 4 and 7 days after WBI, mice were
humanely euthanized for whole blood, serum and tissue
collection as described in previous reports [18]. The mice
were deeply anesthetized prior to collecting whole blood
through a cardiac blood draw and confirmatory cervical
dislocation was performed while the animal was still
anesthetized in accordance with the approved IACUC
protocol. The blood was immediately divided into
two tubes. The samples in EDTA tubes were used for
peripheral blood cell counts by a clinical hematology
analyzer (Bayer Advia 120, Bayer, Tarrytown, NY) at the
AFRRI Veterinary Sciences Department facility, and
samples in BD Microtainer Gold tubes were left unmoved
on racks. Following 30 min coagulation at room temper-
ature, sera were well separated from the gel by 10 min-
centrifugation at 10,0009g, collected and stored at
-80 C for later study. After blood collection and
euthanasia were completed for an individual mouse, tis-
sues were collected. BM cells were collected from mouse
femurs and humeri. After erythrocytes were lysed with
lysis buffer (Qiagen GmbH, Hilden, Germany), total BM
myeloid cells were collected for further use. Mouse
spleens were excised, rinsed with phosphate buffered
saline (PBS), and snap-frozen in liquid nitrogen, then
stored at -80 C for further use.
Micro-RNA (miRNA) extraction and quantitative
real-time polymerase chain reaction (PCR)
Total RNA and miRNA from human CD34? cells were
extracted using mirVana miRNA isolation kits (Life
Technologies) and miRNA from mouse serum was isolated
using mirVana PARIS Kit (Ambion, Cat#AM1556) fol-
lowing the manufacturer’s protocol as reported previously
[14, 15]. RNA concentrations were determined by mea-
suring OD on a NanoDrop spectrophotometer ND-1000
(Thermo Fisher Scientific, Waltham, MA) and total RNA
quality was verified on the Agilent 2100 bioanalyzer
(Agilent Technologies, Palo Alto, CA) with RNA 6000
Nano chips. Reverse transcription (RT) was performed
using TaqMan MicroRNA Reverse Transcription Kits
(Applied Biosystems, Foster City, CA) according to the
manufacturer’s instructions, and the resulting cDNAs were
quantitatively amplified in triplicate for miR-30b and -30c
expression using TaqMan MicroRNA specific primers for
miR30b (ID#000602), miR30c (ID#000419) and U6
(ID#001973) on an IQ5 Real-Time PCR System (Bio-Rad,
Hercules, CA). miRNA levels were normalized to U6 as an
internal control [14].
Pre-miRNA, miRNA inhibitor transfection
Pre-miR30 (PM11060), miR30-inhibitor (AM11060) or
control-miRNA were purchased from Thermo Fisher Sci-
entific (Grand Island, NY) and transfected into CD34? cells
using the Lipofectamine RNAiMAX (Cat# 13778-075,
Invitrogen) according to the manufacturer’s protocol dis-
cussed in our previous report [14]. In brief, the diluted small
RNA was mixed with Lipofectamine RNAiMAX transfec-
tion agent and incubated at room temperature, and then
dispensed into a culture plate. We then overlaid 106
CD34? cell suspensions onto the transfection complexes
and gently tilted the plate to mix. Cells were incubated at
37 C for 24 h and then harvested for further analysis.
Protein extraction and immunoblotting
The frozen mouse tissues or cultured human CD34? cells
were homogenized in 1 9 radio-immunoprecipitation lysis
buffer (RIPA, Sigma-Aldrich, St Louis, MO) supplemented
with a protease inhibitor tablet by tissue homogenizer (Fast
Prep-24, MP Biomedicals, Solon, OH), following manu-
facturer recommendations. After 15 min centrifugation at
12,0009g, the supernatant was collected and protein con-
centrations were determined using a BCA assay kit (Pierce,
Rockford, IL). The collected cell homogenates were
denatured in Laemmli buffer supplemented with DTT
(dithiothreitol), and the same amount of protein from each
sample (100–120 lg) was loaded for SDS-PAGE elec-
trophoresis. Subsequently, immunoblotting was performed
following standard procedures with an enhanced chemilu-
minescence kit (Thermo Scientific, Rockford, IL). The
images were captured by CCD camera and the optical
densities of protein bands were quantified using Image-
Gauge software as previously described [15]. Antibodies
for Mcl-1, Bcl-XL, Bcl-2, Bim, Bax, Bak, cH2AX, cyto-
chrome c, Caspase-3 and caspase-7 were purchased from
Cell Signaling (Minneapolis, MN) and Santa Cruz (Santa
Cruz Biotechnology, Dallas, TX), and beta-actin was
obtained from Sigma-Aldrich (St Louis, MO).
Clonogenic assay
Total live BM myeloid cells from each mouse and human
CD34? cells were measured by Trypan blue staining.
Clonogenicity of mouse BM cells and human CD34? cells
was quantified in standard semisolid cultures in triplicate
using 1 ml of Methocult GF ? system for either mouse
cells or human cells (StemCell Technologies) according to
the manufacturer’s instructions, as described previously
[15]. Briefly, mouse BM cells from pooled samples or
CD34? cells from liquid culture were washed twice with
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IMDM (Iscove’s Modified Dulbecco’s Media) and seeded
at 1 9 104 cells/dish (mouse cells) or 3 9 103 cells/dish
(CD34? cells) in 35-cm cell culture dishes (BD Bio-
sciences). Plates were scored for colonies after culturing
for 10 days (for mouse colonies) or 14 days (for human
colonies) at 37 C in 5 % CO2.
Luciferase reporter assay
To construct pMIR-REPORT-Mcl-1-30 UTR-WT and
pMIR-REPORT-Mcl-1-30 UTR-MUT plasmids, a wild
type 30 UTR segment of human Mcl-1 mRNA (1198-1725
nt, Genebank accession No. NM_021960) containing
two putative miR-30 binding sites (1329–1351 and
1584–1602 nt) or a corresponding multi-base mutant
sequence was cloned into the SacI and HindIII sites
downstream of the firefly luciferase reporter gene in pMIR-
REPORT Luciferase (Ambion, Austin, TX, USA) by
BioInnovatise, Inc. (Rockville, MD). These reporters were
transfected into human CD34? cells using Lipofectamine
2000 (Thermo Fisher Scientific, Grand Island, NY, USA)
and transfection efficiency was corrected by a p-MIR-re-
port-b-gal control vector (Ambion, Austin, TX, USA). The
Ambion pre-miR-30 precursors were co-transfected with
pMIR-report, pMIR-hMcl-1-WT, or pMIR-hMcl-1-MUT
plasmid. Luciferase and b-galactosidase activity were
determined using Dual-Light System (Applied Biosystems,
Bedford, MA, USA).
Statistical analysis
Fisher’s exact test was used to compare survival among
groups at the end of 30 days. Differences between means
were compared by ANOVA and Student’s t tests. p\ 0.05
was considered statistically significant. Results are pre-
sented as means ± standard deviations or standard errors
of the mean as indicated.
Results
30-day survival study of mice exposed to 60Co-
radiation
CD2F1 male mice were whole-body irradiated (WBI)
with a single radiation dose 5, 8 or 9 Gy, at a dose rate of
0.6 Gy/min in the AFRRI 60Co radiation facility
(N = 20/group). Figure 1a illustrates the 30-day survival
curves for mice exposed to 5, 8, and 9 Gy; survival rates
were as follows: 5 Gy (100 %), 8 Gy (75 %), and 9 Gy
(30 %). Lethal doses of 8 or 9 Gy caused significant
animal death compared with the 5 Gy sublethal radiation
dose.
Radiation inhibited mouse BM hematopoietic stem
and progenitor and peripheral blood cells
BM cells were collected from femurs and humeri of mice
24 h after 5, 8 and 9 Gy irradiation. Total live BM myeloid
cells from each mouse were measured by trypan blue
staining. Clonogenicity was compared between samples
collected from individual mice after different doses of
WBI. Figure 1b shows the significant decreased colony
numbers in irradiated mouse BM, in comparison with
sham-irradiated control (N = 6, p\ 0.01). Furthermore,
peripheral blood was collected from sham- or c-irradiated
mice. Blood counts were measured on 1, 3 and 7 days post-
irradiation. Consistent with clonogenicity results, a severe
reduction in radiation-induced blood cells was observed in
mice that received 5, 8 or 9 Gy of WBI. Figure 1c illus-
trates the total white blood cells (WBC), absolute neu-
trophil counts (ANC), absolute lymphocyte counts (ALC),
and platelets (PLT) measured in whole blood at the indi-
cated time points post-irradiation (N = 6). WBC and ALC
were significantly reduced for all radiation doses at day 1
after irradiation and remained below baseline levels though
the last time point, 7 days after irradiation. ANC gradually
decreased from day 1 to day 3 for all radiation doses and
began to recover by day 7 after 5 Gy irradiation, whereas
mice exposed to radiation doses[5 Gy were exhibited low
ANC levels through day 7. The loss of PLT started later
and dropped sharply after day 3, in a radiation dose-de-
pendent manner. Reductions in red blood cell counts were
minor after WBI (data not shown).
Radiation induced apoptotic factor activation
in mouse BM and spleen cells
It was suggested that Mcl-1 is essential for survival of early
cells, including embryonic cells, and hematopoietic stem
and progenitor cells [19]. In contrast, anti-apoptotic effects
of Bcl-2 were observed in mature cells [20]. To identify
impacts of radiation on apoptosis of hematopoietic stem
and progenitor cells, we examined antiapoptotic factors
Bcl-2, Bcl-XL and Mcl-1 and proapoptotic factors Bax and
Bak, as well as caspase-3 activation and c-H2AX expres-
sion in mouse BM. BM cells were collected from mouse
femurs and humeri at indicated times after 5, 8 or 9 Gy
irradiation, and lysates were generated as pooled samples
due to low cell numbers after irradiation (N = 6). Western
blot results in Fig. 2a indicate DNA damage marker c-
H2AX upregulation was initiated at 4 h after 5–9 Gy WBI
and was continually expressed up to 1 day after 8 and 9 Gy
irradiation. Inhibition of Mcl-1 expression started at 4 h
after 9 Gy, and Mcl-1 was undetectable from 1 to 3 days
after 5-9 Gy. Four days after irradiation, Mcl-1 recovered
to normal levels after 5 Gy, and partially recovered after
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8 Gy. No Mcl-1 was observed in 9 Gy irradiated samples
4 days after WBI. Interestingly, the anti-apoptotic factor
Bcl-2 in mouse BM cells was not significantly downregu-
lated by 5–9 Gy radiation, except for 4 days after 9 Gy.
The ratios of Mcl-1 and Bcl-2 vs. b-actin are shown in
Fig. 2b. In contrast to Mcl-1 downregulation, levels of
proapoptotic factors Bax and Bak were enhanced by radi-
ation and the apoptosis executor caspase-3 was activated
1 day after WBI. Bcl-XL protein was undetectable in
mouse BM cells (data not shown).
We next examined radiation-induced apoptosis signal-
ing in mouse spleen cells 4 h, and 1, 3 and 4 days after
0, 5, 8 or 9 Gy irradiation. Spleens were harvested
(N = 6/group) and whole spleen lysates were generated as
pooled samples. Immunoblotting for these samples was
performed to analyze apoptotic cascade proteins, including
antiapoptotic factors Mcl-1, Bcl-2, and Bcl-XL and
proapoptotic factors Bim, Bax and Bak. Radiation inhibited
antiapoptotic factors and upregulated proapoptotic factors
in a radiation dose-dependent manner as shown in Fig. 3a.
Eight and 9 Gy WBI suppressed Mcl-1 expression at every
time point; whereas, the decrease of Mcl-1 expression in
5 Gy irradiated spleen samples was observed 1 and 3 day
post-WBI, and started recovery by day 4 after radiation.
Effects of radiation on Bcl-2 expression were relatively
minor; the ratios of Mcl-1 and Bcl-2 vs. b-actin are shown
in Fig. 3b. The Bcl-XL protein level was very low to
undetectable in mouse spleen cells (data not shown). The
irreversible apoptosis-inducer cytochrome c was highly
expressed in all irradiated mouse spleen samples except
those from 4 days after 5 Gy. Consistent with cytochrome
c release, the activation of apoptotic executors caspase-3
and caspase-7, shown as cleaved lower molecular weight
bands in the western blot image, occurred in the irradiated
spleens and peaked at day 1(caspase-7) and day 3 (caspase-
3) after WBI, respectively (Fig. 3c). Both caspase-3 and
caspase-7 activation returned to undetectable baseline
levels as in sham-irradiated samples 4 days after 5 Gy.
Mcl-1 was highly suppressed by radiation in human
CD341 cells
We next evaluated the effects of radiation on Mcl-1, Bcl-
XL and Bcl-2 expression in human CD34? cells. The cells
were irradiated at doses of 0, 0.5, 1.0 or 2.0 Gy and sam-
ples were collected at 24 and 48 h after irradiation. Data
Fig. 1 30-day survival study, BM cell clonogenicity and blood cell
counts inmice after 60Cowhole-body irradiation (WBI). aCD2F1mice
were irradiatedwith a single radiation dose of 5, 8 or 9 Gy, at a dose rate
of 0.6 Gy/min in the AFRRI 60Co radiation facility (N = 20/group).
The 30-day survival curves for 5, 8 and 9 Gy reflect an approximate
LD0/30, LD25/30, and LD70/30, respectively. Mean ± SD. **
p\ 0.01, 5 Gy irradiation vs. 8 or 9 Gy irradiated controls. b Clono-
genicity of mouse BM cells was quantified in standard semisolid
cultures in triplicate. Colonies were counted 10 days later. Results were
from one representative experiment of two independent experiments
(N = 6 mice/point/experiment). Mean ± SD. ** p\ 0.01, radiation
vs. sham-irradiated controls. c Total white blood cells (WBC), absolute
neutrophil counts (ANC), absolute lymphocyte counts (ALC), and
platelets (PLT) were measured in whole blood samples 1, 3 and 7 days
after radiation (N = 6). Mean ± SD. * p\ 0.05; ** p\ 0.01,
radiation vs. sham-irradiated controls
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from the immunoblotting assay (Fig. 4a) showed Mcl-1
was suppressed, and Bax expression was highest, at 24 h
after 2 Gy irradiation. At 48 h after 0.5–2 Gy of irradia-
tion, Mcl-1 expression was further decreased. However, the
impact of radiation on Bcl-2 expression in CD34? cells
was not significant as shown by Bcl-2/actin ratios (Fig. 4b).
Bcl-XL protein was undetectable in CD34? cells (data not
shown). Consistent with the Mcl-1 downregulation shown
by immunoblotting, survival of CD34? cells significantly
decreased from 95 % (sham-irradiated) to 61 and 48 %
48 h after radiation at 1 and 2 Gy (Fig. 4c), and colony
formation numbers decreased from 560 ± 30/3000
CD34? cells (control) to 230 ± 15/3000 CD34? cells
(after 1 Gy) and 134 ± 11/3000 CD34? cells (after 2 Gy)
(Fig. 4d), (p\ 0.01).
Radiation-induced Mcl-1 downregulation
was miRNA-30 dependent
We previously reported that miR-30 played a key role in
radiation-induced human CD34? and osteoblast cell damage
through an apoptotic pathway [14], and a radiation counter-
measure candidate, delta-tocotrienol (DT3), suppressed radi-
ation-induced miR-30 expression in mouse BM, liver,
jejunum and serum, and in human CD34? cells, and pro-
tected mouse and human CD34? cells from radiation expo-
sure [15]. In this study, expression of miR-30b and miR-30c
was determined in mouse serum at 4 h, and 1, 3 and 4 days
after 5, 8 or 9 Gy irradiation, since miR-30 levels in serum
were parallel to expression in BM after radiation [15]. We
found that bothmiR-30b andmiR-30cwere highly induced by
5–9 Gy within 4 h in serum, in a radiation dose-dependent
manner (Fig. 5a). The levels of serum miR-30s 24 h post-
radiation dropped in all samples, but were still significantly
higher than control in 8 and 9 Gy irradiated samples as shown
in Fig. 5a.
We further asked whether increases of miR-30 are
responsible for radiation-induced Mcl-1 repression in
hematopoietic cells. To answer this question, we ana-
lyzed potential targets of miR-30 family members using
the miRNA target prediction database RNAhybrid 2.2
(http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/) [21],
and found that members of the miR-30 family were
predicted to target the antiapoptosis factor Mcl-1. Fig-
ure 5b shows putative binding sites for miR-30b and
miR-30c in the 30UTR of the Mcl-1 gene. Hence we
explored interactions between the miR-30 family and
Mcl-1.
Fig. 2 Radiation induced apoptotic factor activation in mouse BM
cells. BM cells were collected from mouse femurs and humeri at 4 h,
and 1, 3 and 4 days after 5, 8 or 9 Gy irradiation, and lysates were
generated as pooled samples (N = 6). a Immunoblotting was
performed to determine protein expression of Mcl-1, Bcl-2, Bax,
Bak, c-H2AX, and caspase-3 in these samples. b b-Actin was used as
a control for sample loading. The ratios of Mcl-1 and Bcl-2 vs. b-actin
are shown. Results are from one representative experiment of two
independent experiments (6 mice/group/experiment)
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The effects of miR-30 on Mcl-1 expression in
CD34? cells were evaluated using gain and loss of miR-30
expression. CD34? cells were transfected with miR-30
inhibitor, precursors (pre-miR30) or control-miR from Life
Technologies Co.; miR-30b and miR-30c expression were
examined by quantitative RT-PCR 24 h post-transfection
and U6 was used as a control. Results shown in Fig. 6a
demonstrate that transfection of pre-miR-30 enhanced both
miR-30b and miR-30c expression more than 100-fold and
transfection of inhibitor suppressed miR-30b and miR-30c
expression by[50-fold in CD34? cells. Western blot
assays were used to test Mcl-1 and Bcl-2 expression in non-
transfected, miR-control, inhibitor and pre-miR-30 trans-
fected CD34? cells as shown in Fig. 6b. Forty-eight h after
pre-miR-30 transfection, the level of Mcl-1 expression in
CD34? cells was inhibited significantly, whereas no Mcl-1
downregulation was shown in control- or miR-30-inhibitor
transfected samples compared with non-transfection control
(Fig. 6c). Antiapoptosis factor Bcl-2 was not impacted by
miR-30 overexpression in these cells (Fig. 6b, c).
Fig. 3 Radiation induced apoptotic factor activation in mouse spleen
cells. Spleens were collected and whole spleen lysates from each
group (N = 6) were generated as pooled samples. Immunoblotting
was performed to determine protein expression of a Mcl-1, Bcl-2,
Bim, Bax, Bak, and cytochrome c and b the ratios of Mcl-1 and Bcl-2
vs. b-actin. c Caspase-3 and caspase-7 expression and activation. b-
actin was used as a control for sample loading. Results are from one
of two experiments (6 mice/group/experiment)
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Fig. 4 Mcl-1 was highly suppressed by radiation in human
CD34? cells. CD34? cells were irradiated at doses of 0, 0.5, 1.0
or 2.0 Gy (0.6 Gy/min) and samples were collected at 24 and 48 h
after irradiation. a Immunoblotting was performed to determine
protein expression of Mcl-1, Bcl-2, and Bax in these samples. b b-
Actin was used as a control for sample loading. The ratios of Mcl-1
and Bcl-2 vs. b-actin are shown. c Human CD34? cell expansion and
viability (trypan blue-negative cells) from all groups were quantified.
d Clonogenicity of human hematopoietic progenitor CD34? cells
was quantified in standard semisolid cultures in triplicate. Colonies
were counted 14 days later. Results from one representative exper-
iment of three independent experiments were showed. Mean ± SD.
** p\ 0.01, sham-control vs. irradiated
Fig. 5 MiR-30 expression in mouse serum after c-irradiation.
MiRNAs were extracted from mouse serum. Levels of miR-30b and
miR-30c expression were determined by Quantitative Real Time-RT
PCR in mouse (a) Serum at 4 h, and 1, 3 and 4 days after 5, 8 or 9 Gy
irradiation. U6 was used as a control. Results represent one of three
independent experiments. RQ relative quantification. N = 6/group in
each experiment; Mean ± SD. * p\ 0.05, ** p\ 0.01; radiation vs.
sham-control. b MiR-30b and miR-30c binding sites in Mcl-1 30UTR
are shown
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Knockdown of miR-30 blocked radiation-induced
Mcl-1 reduction in CD341 cells
We next examined the effects of miR-30 on Mcl-1
expression in CD34? cells after radiation. The cells were
exposed to different doses of c-radiation at 24 h after non-
transfection, miR-control, or miR-30 inhibitor transfection,
and Mcl-1 and Bcl-2 protein expressions were tested by
western blot in samples collected at 24 h (48 h post-
transfection) and 48 h (72 h post- transfection) after irra-
diation. Figure 7a shows radiation upregulated proapop-
totic factor Bax and downregulated Mcl-1 expression in
non-transfected and control-miR-transfected CD34? cells
24 h after 2 Gy and 48 h after 1 and 2 Gy irradiation,
respectively. Transfection of miR-30 inhibitor significantly
protected Mcl-1 from radiation-mediated downregulation
and maintained the Mcl-1 levels as in sham-irradiated
CD34? cells. As expected, Bcl-2 expression was not
changed by radiation nor miR-30 inhibition in
CD34? cells. The ratio of Mcl-1 or Bcl-2 vs. b-actin at
48 h post-irradiation is shown in Fig. 7b. In addition,
radiation-induced Bax expression was completely blocked
by knockdown of miR-30 in CD34? cells.
Next, we asked whether the negative effect of miR-30
on Mcl-1 expression was direct. To answer this question,
we set up a luciferase reporter assay as described in
Materials and Methods. The putative miR-30 binding sites
were predicted using target prediction programs RNAhy-
brid 2.2 [21]. There are two putative miR-30 binding sites
in the 30UTR of Mcl-1 (1329-1351 and 1584–1602 nt, with
the 50 end of the miR-30 seed sequence in the latter) and
the alignment of miR-30 with the 30UTR insert is illus-
trated in Fig. 7c. The firefly luciferase -report vector
plasmid (p-MIR, Ambion, Austin, TX, USA) was modified
Fig. 6 Over-expression of miR 30 in CD34? cells inhibited Mcl-1
protein expression. Pre-miR30, miR30 inhibitor (si-miR30), or
control miR (CT-miR) molecules were transfected into CD34? cells.
miR-30b and miR-30c expression were examined 24 h post-transfec-
tion by quantitative RT-PCR. U6 was used as a control. RQ relative
quantification. a Transfection of pre-miR-30 enhanced both miR-30b
and miR-30c expression more than 100-fold and transfection of
inhibitors suppressed miR-30b and miR-30c expression by[50-fold
in CD34? cells. b Mcl-1 and Bcl-2 expression in non-transfected,
miR-control, inhibitor and pre-miR-30 transfected CD34? cells were
evaluated by immunoblotting 24 and 48 h after transfection. Levels of
Mcl-1 expression in CD34? cells were significantly inhibited 48 h
after pre-miR-30 transfection, whereas Bcl-2 was not impacted by
miR-30 overexpression in these cells. c The ratios of Mcl-1 and Bcl-2
vs. b-actin were measured in different treatment groups
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by insertion of the Mcl-1-derived mir-30 binding sites or a
multi-base mutant into the 30UTR. The p-MIR-report
vector with Mcl-1 30UTR (pMIR-hMcl-1 30UTR) and
p-MIR-report vector with mutant 30UTR (pMIR-MUT
30UTR) were constructed by BioInnovatise, Inc. (Rock-
ville, MD). These reporters were transfected into human
CD34? cells, and transfection efficiency was corrected by
a p-MIR-report-b-gal control vector (Ambion, Austin, TX,
USA). The Pre-miRNA-30 Precursor was co-transfected
where indicated in Fig. 7d. As shown in Fig. 7d, cotrans-
fection of CD34? cells with the parental firefly luciferase
reporter construct (pMIR-vector control) plus the pre-mir-
30 does not significantly change the expression of the
reporter. However, when the mir-30 target site from the
Mcl-1 30UTR is inserted into the luciferase construct
(pMIR-hMcl-1), expression of luciferase is strongly
decreased when cotransfected with pre-miR-30. This sup-
pression is abolished by mutation of the binding sites
(pMIR-MUT). The effect of miR-30 occurred only when
both miR-30 and its target sequence were present; sug-
gesting that miR-30 directly inhibits the expression of Mcl-
1 through binding to its target sequence in Mcl-1gene.
Discussion
Hematopoietic cells are very sensitive to radiation
and C1 Gy of radiation could result in DNA damage and
apoptosis in these cells. Our results in Fig. 1 confirm
whole-body irradiation (WBI)-induces severe mouse
hematopoietic cell damage, and even a 5 Gy sublethal dose
of WBI caused critical decreases in hematopoietic stem and
progenitor cells in mouse BM and suppressed mouse blood
cell counts. It was suggested that radiation as an intrinsic
apoptotic stimulus initiates mammalian cells’ apoptotic
program [5]. However, the nature of the anti- and pro-
apoptosis regulation in response to radiation is largely
unknown. Understanding individual contributions of radi-
ation-induced apoptosis is important in the development of
new radioprotection, mitigation as well as treatment
strategies. Our results demonstrate that antiapoptosis factor
Mcl-1 is very sensitive to c-radiation and moderate doses
(5 Gy WBI in mouse and 0.5 Gy in human CD34? cells)
of radiation can suppress Mcl-1 expression in both mouse
BM and spleen and human CD34? cells. In contrast, Bcl-2
expression was relatively stable after radiation exposure in
these cells. Bcl-XL expression in irradiated and unirradi-
ated mouse BM and spleen cells, and CD34? cells, was
very low to undetectable in our study.
Although Bcl-2, Bcl-XL and Mcl-1 share Bcl-2 homol-
ogy (BH) domains [22], differential effects of these anti-
apoptotic Bcl-2 family members on survival of cells have
been reported [23–26]. Among them, Mcl-1 is structurally
unique in comparison with other antiapoptotic Bcl-2 family
members. Mcl-1 has a longer amino terminus (N-terminus)
than other Bcl-2 family members, which contains numbers
of functional modification regions [27, 28]. On the outer
mitochondrial membrane (OMM), Mcl-1, similar to other
antiapoptotic Bcl-2 family members, inhibits apoptotic cell
death by binding and sequestering the proapoptotic pro-
teins Bax and Bak. However, when targeted to the mito-
chondrial matrix (Matrix), Mcl-1 initiates mitochondrial
function, including promoting normal ATP production,
efficient oxidative phosphorylation, and reducing produc-
tion of reactive oxygen species [28, 29]. These two sepa-
rable functions may play critical roles in promoting cell
survival. Thus, Mcl-1 may possess multiple functions on
survival of cells.
It is well known that Mcl-1 is essential for embryonic
development [19], survival of lymphocytes [30],
hematopoietic stem cells [31] and neutrophils [32, 33].
Campbell et al. [31] reported that Mcl-1 but not Bcl-2 and
Bcl-XL was an indispensable regulator of self-renewal and
is highly expressed in human hematopoietic stem cells.
Knockdown of Mcl-1 in ontogenetically primitive human
pluripotent stem cells resulted in complete ablation of stem
cell self-renewal function. Further, mcl-1 gene deletion
caused severe reductions of mouse BM cells [34], whereas
Bcl-2 deficient mice did not show problems in early
hematopoiesis [20]. Consistent with these reports, in our
current study we found that Mcl-1 was significantly
downregulated after radiation in mouse BM and human
CD34? cells, whereas Bcl-2 expression was relatively
bFig. 7 MiR-30 regulated Mcl-1 protein expression in CD34 ? cells
after c-irradiation. a Endogenous Mcl-1, Bcl-2 and Bax protein levels
were measured by western blot assays after non-, control-miR (CT-
miR), or miR30-inhibitor transfection and c-irradiation in
CD34? cells. Radiation downregulated Mcl-1 and enhanced Bax
expression in non- or CT-miR transfected samples, whereas trans-
fection of miR30-inhibitor maintained Mcl-1 protein levels and
suppressed Bax expression in CD34? cells 24 and 48 h after
irradiation. Bcl-2 expression was not impacted by radiation and/or
gene transfection. b The ratios of Mcl-1 and Bcl-2 vs. b-actin were
measured in different treatment groups 48 h after 0, 0.5, 1, or 2 Gy
irradiation. c Two putative miR-30 binding sites in the 30UTR of Mcl-
1 (1329–1351 and 1584–1602 nt) and the alignment of miR-30 with
the 30UTR insert are illustrated. A mutation was generated on the
Mcl-1 30-UTR sequence in the complementary site and the 50end seed
region of miR-30, as indicated. d The firefly luciferase p-MIR-report
vector (pMIR) as a control, p-MIR-report vector with Mcl-1 30UTR
(pMIR-hMcl-1), and p-MIR-report vector with mutant 30UTR (pMIR-
MUT) were transiently transfected or cotransfected with an expres-
sion plasmid for pre-mir-30 into human CD34? cells. Luciferase
activity in CD34? cells transfected with pMIR alone, or pre-miRNA-
30 precursor cotransfected with pMIR-control, pMIR-hMcl-130UTR,
or pMIR-MUT 30UTR is shown. Mean ± SD. (N = 3) ** p\ 0.01;
pMIR-hMcl-1 30UTR cotransfected with pre-miRNA-30 compared to
pMIR-control or pMIR-MUT 30UTR and pre- miRNA-30 precursor
cotransfected cells
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stable and not significantly impacted by radiation exposure
in these cells.
Our previous studies suggested miR-30 is an apoptosis
inducer in mouse and human hematopoietic cells. Radio-
protector delta-tocotrienol suppressed miR-30 expression
in mouse serum and cells and in human CD34? cells, and
protected mouse and human CD34? cells from radiation
exposure [14, 15]. However, the specific role of miR-30 in
radiation-induced apoptotic cell death and its downstream
target factors which caused mouse and human
hematopoietic cells damage are not well understood. A
number of studies have examined the general and specific
effects of miRNA perturbation in radiation-exposed cells
and evidence for miRNA involvement in the radiation
response is increasing [35–37]. In the current study, we
demonstrated increased levels of miR-30b and miR-30c in
mouse serum after 5–9 Gy WBI, and this increase was
radiation dose-dependent. Furthermore, we found putative
miR-30 binding sites in the 30UTR of Mcl-1 mRNA
(Fig. 5b) and demonstrated for the first time that miR-30
directly inhibits the expression of Mcl-1 by binding to its
target sequences (Fig. 7c, d). Previously we reported that
knockdown of miR-30 before irradiation significantly
increased clonogenicity in irradiated human CD34? cells
[14]. In the current study as shown in Fig. 7a and b, we
further demonstrated that knockdown of miR-30 before
irradiation in human CD34? cells blocked radiation-in-
duced reduction of Mcl-1, and the proapoptotic factor Bax
was no longer increased by radiation. In contrast, Bcl-2
expression was not affected by miR-30 in these cells. Thus,
our data from the current study suggest an important
downstream target of miR-30 in irradiated hematopoietic
cells is Mcl-1, and miR-30 is responsible for radiation-
induced apoptosis in mouse and human hematopoietic cells
through targeting the antiapoptotic factor Mcl-1.
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